A 52-year-old man with chronic gout is on azathioprine for autoimmune hepatitis. He is started on allopurinol for recurrent gouty attacks. What is the major risk of this combination?
- A Bone marrow suppression due to azathioprine toxicity ✓
- B Acute gout flare
- C Severe hepatotoxicity
- D Renal failure
Explanation
Allopurinol inhibits xanthine oxidase, the enzyme responsible for metabolising azathioprine to inactive metabolites. When allopurinol is co-administered, azathioprine levels rise markedly, leading to severe bone marrow suppression, including leukopenia and thrombocytopenia. The azathioprine dose should be reduced to 25-33% of the usual dose when combined with allopurinol, or an alternative urate-lowering agent should be chosen. Hepatotoxicity and renal failure are not the primary concern with this interaction.
Reference: Katzung's Basic and Clinical Pharmacology, 15th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.